WEBINAR: How to make TXA affordable and available to all women diagnosed with postpartum haemorrhage
WEBINAR: How to make TXA affordable and available to all women diagnosed with postpartum haemorrhage
Breaking down barriers: How to make TXA affordable and available to all women diagnosed with postpartum haemorrhage
9 July 2026
13:00 BST | Online
Tranexamic acid (TXA) is a proven, life-saving treatment that reduces deaths from severe postpartum bleeding, yet too many women still cannot access it because it is unavailable or unaffordable.
This is especially urgent in many countries in Africa and South Asia, where the cost of inaction is far greater than the price of the drug.
Join Jhpiego and the London School of Hygiene & Tropical Medicine (LSHTM) for a webinar exploring how new evidence and innovations, including intramuscular TXA, could expand access.
Hear from the AMPLI‑PPHI project and LSHTM’s WOMAN Trials as they share practical strategies for procurement, pricing, and supply chain improvements to make TXA more affordable and save more maternal lives.
